桑白皮汤治疗慢性阻塞性肺疾病急性加重期临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R563.9

基金项目:


Clinical Study on Sangbaipi Decoction for Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察桑白皮汤治疗慢性阻塞性肺疾病急性加重期(AECOPD) 的临床效果,并观察其对患 者肺功能、呼出气一氧化氮(FeNO) 水平的影响。方法:选择90 例AECOPD 患者为研究对象并随机分为对 照组及观察组各45 例。对照组接受常规抗感染治疗,观察组在对照组基础上联合桑白皮汤治疗。比较2 组临 床疗效,比较2 组治疗前后肺功能指标以及血清高敏C-反应蛋白(hs-CRP)、肿瘤坏死因子-α (TNF-α)、 FeNO 水平、中医证候积分。结果:治疗前,2 组第1 秒用力呼气容积占预计值的比值(FEV1/pre)、第1 秒用 力呼气容积和用力肺活量的比值(FEV1/FVC) 及FeNO 水平比较,差异无统计学意义(P>0.05);治疗后, 2 组FEV1/pre、FEV1/FVC 均升高(P<0.05),FeNO 水平均降低(P<0.05),且观察组FEV1/pre、FEV1/FVC 高 于对照组(P<0.05),FeNO 水平低于对照组(P<0.05)。治疗前,2 组血清hs-CRP、TNF-α 水平比较,差异 无统计学意义(P>0.05);治疗后,2 组血清hs-CRP、TNF-α 水平均降低(P<0.05),且观察组低于对照 组(P<0.05)。治疗前,2 组中医证候积分比较,差异无统计学意义(P>0.05);治疗后,2 组中医证候积分 均降低(P<0.05),且观察组低于对照组(P<0.05)。治疗后,观察组治疗总有效率93.33%,高于对照组 80.00%(P<0.05)。结论:桑白皮汤治疗AECOPD,可有效降低患者炎症因子及FeNO 水平,改善患者肺功能。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Sangbaipi Decoction for acute exacerbation of chronic obstructive pulmonary disease(AECOPD) and its effect on lung function and levels of Fractional exhaled nitric oxide(FeNO). Methods:A total of 90 cases of AECOPD patients were selected as the study subjects and randomly divided into the control group and the observation group, with 45 cases in each group. The control group was treated with routine anti- infection therapy,and the observation group was additionally treated with Sangbaipi Decoction based on the treatment of the control group. The clinical effects in the two groups were compared. Before and after treatment,the indexes of lung function,the levels of high- sensitivity C- reactive protein(hs- CRP), tumor necrosis factor- α(TNF- α) and FeNO in serum,and traditional Chinese medicine(TCM) syndrome scores were compared between the two groups. Results:Before treatment,there was no significant difference being found in the comparison of the ratio of forced expiratory volume in one second to predicted value(FEV1/pre), the ratio of forced expiratory volume in one second to forced vital capacity(FEV1/FVC) and FeNO levels between the two groups(P>0.05). After treatment,FEV1/pre and FEV1/FVC in the two groups were increased(P<0.05),and FeNO levels were decreased(P<0.05);FEV1/pre and FEV1/FVC in the observation group were higher than those in the control group(P<0.05), and FeNO levels was lower(P<0.05). Before treatment, there was no significant difference being found in the comparison of levels of hs-CRP and TNF-α in serum between the two groups (P>0.05). After treatment,the levels of hs-CRP and TNF- α in serum in the two groups were decreased (P<0.05), and the levels in the observation group were lower than those in the control group(P<0.05). Before treatment, there was no significant difference being found in the comparison of TCM syndrome scores between the two groups(P>0.05). After treatment, the TCM syndrome scores in the two groups were decreased(P<0.05),and the score in the observation group was lower than that in the control group (P<0.05). After treatment,the total effective rate was 93.33% in the observation group,higher than that of 80.00% in the control group(P<0.05). Conclusion: Sangbaipi Decoction for AECOPD patients can effectively reduce levels of inflammatory factors and FeNO,and improve their lung function.

    参考文献
    相似文献
    引证文献
引用本文

俞宁宁,陈琼琰.桑白皮汤治疗慢性阻塞性肺疾病急性加重期临床研究[J].新中医,2023,55(1):36-39

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-01-17
  • 出版日期:
文章二维码